Put Options

11 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $2.93 Million - $3.57 Million
-17,900 Reduced 89.5%
2,100 $414,000
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $526,286 - $614,584
3,400 Added 20.48%
20,000 $3.43 Million
Q1 2024

May 10, 2024

SELL
$159.82 - $182.1 $12.2 Million - $13.9 Million
-76,500 Reduced 82.17%
16,600 $3.02 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $280,539 - $324,765
2,100 Added 2.31%
93,100 $13.9 Million
Q2 2023

Aug 15, 2023

SELL
$132.51 - $164.9 $5.21 Million - $6.48 Million
-39,300 Reduced 30.16%
91,000 $12.3 Million
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $3.96 Million - $4.56 Million
27,400 Added 26.63%
130,300 $20.8 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $14.2 Million - $17 Million
102,500 Added 25625.0%
102,900 $16.6 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $19.7 Million - $24.5 Million
-149,600 Reduced 99.73%
400 $65,000
Q4 2020

Feb 09, 2021

BUY
$80.49 - $108.67 $11.8 Million - $16 Million
146,900 Added 4738.71%
150,000 $53,000
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $95,381 - $127,634
-1,300 Reduced 29.55%
3,100 $15,000
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $283,800 - $430,276
4,400 New
4,400 $12,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.